URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

William Martens

Concepts (101)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Myotonic Dystrophy
9
2004
209
1.240
Why?
Myotonia
4
2007
42
0.680
Why?
Spinal Muscular Atrophies of Childhood
3
2007
12
0.530
Why?
Hand Strength
4
2005
33
0.520
Why?
Exercise Test
2
2010
88
0.370
Why?
Disability Evaluation
3
2007
125
0.360
Why?
Muscular Atrophy, Spinal
2
2010
15
0.360
Why?
Fatigue
2
2010
122
0.340
Why?
Motor Activity
2
2007
179
0.300
Why?
Severity of Illness Index
5
2004
878
0.300
Why?
Muscle, Skeletal
3
2004
409
0.250
Why?
Patient Selection
2
2010
197
0.210
Why?
Muscle Weakness
1
2012
39
0.210
Why?
Rare Diseases
1
2011
27
0.200
Why?
Muscular Dystrophy, Facioscapulohumeral
1
2011
24
0.190
Why?
Male
16
2001
18870
0.190
Why?
Sleep Disorders
1
2012
68
0.190
Why?
Female
16
2001
19061
0.190
Why?
Adult
12
2004
10906
0.190
Why?
Myotonic Disorders
1
2011
29
0.190
Why?
Motor Skills
1
2011
46
0.180
Why?
Muscle Contraction
2
2004
169
0.180
Why?
Registries
1
2011
203
0.180
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2010
14
0.180
Why?
Academic Medical Centers
1
2011
93
0.180
Why?
Mexiletine
1
2010
12
0.180
Why?
Microfilament Proteins
1
2010
61
0.170
Why?
Middle Aged
11
2001
9461
0.170
Why?
Walking
1
2010
40
0.170
Why?
Insulin-Like Growth Factor I
1
2010
98
0.170
Why?
Sex Characteristics
1
2010
138
0.170
Why?
Anti-Arrhythmia Agents
1
2010
80
0.170
Why?
Isometric Contraction
2
2005
47
0.160
Why?
Child Development
1
2011
197
0.160
Why?
Quality of Life
1
2012
486
0.150
Why?
Reproducibility of Results
5
2004
859
0.150
Why?
Recombinant Proteins
1
2010
706
0.150
Why?
Gene Expression Regulation, Developmental
1
2010
329
0.150
Why?
Humans
17
2001
35000
0.150
Why?
Membrane Glycoproteins
1
2010
350
0.150
Why?
Muscle Strength
1
2007
25
0.140
Why?
Young Adult
4
2010
1013
0.140
Why?
Software
1
2007
126
0.140
Why?
Statistics, Nonparametric
3
2010
251
0.130
Why?
Cross-Sectional Studies
3
2010
627
0.120
Why?
Electrodiagnosis
1
2004
49
0.110
Why?
Trinucleotide Repeat Expansion
1
2004
50
0.110
Why?
Neoplasms
1
2009
701
0.110
Why?
Leukocytes
1
2004
191
0.100
Why?
Child
4
2007
3897
0.090
Why?
Myositis, Inclusion Body
1
2001
25
0.090
Why?
Vital Capacity
2
2010
42
0.090
Why?
Aged
5
2001
6986
0.090
Why?
Adolescent
4
2007
4513
0.090
Why?
Child, Preschool
3
2007
2452
0.080
Why?
Muscle Relaxation
2
2007
20
0.080
Why?
Diagnosis, Computer-Assisted
2
2005
64
0.080
Why?
Clinical Trials as Topic
1
2001
664
0.070
Why?
Ulnar Nerve
2
2004
30
0.070
Why?
Age Factors
2
2010
1060
0.070
Why?
Electric Stimulation
2
2004
213
0.070
Why?
Predictive Value of Tests
2
2004
579
0.070
Why?
Disease Progression
2
2001
496
0.060
Why?
Aged, 80 and over
2
2007
2423
0.050
Why?
Chloride Channels
1
2012
69
0.050
Why?
Qualitative Research
1
2012
54
0.050
Why?
Sodium Channels
1
2012
117
0.050
Why?
Knee
1
2011
22
0.050
Why?
Health Surveys
1
2012
198
0.050
Why?
Clinical Laboratory Techniques
1
2011
39
0.050
Why?
Philadelphia
1
2011
9
0.050
Why?
Diagnostic Tests, Routine
1
2011
47
0.050
Why?
Longitudinal Studies
1
2012
372
0.050
Why?
Injections, Subcutaneous
1
2010
89
0.050
Why?
Muscle Strength Dynamometer
1
2010
3
0.040
Why?
Statistics as Topic
1
2011
177
0.040
Why?
Drug Combinations
1
2010
142
0.040
Why?
Health Status Indicators
1
2011
97
0.040
Why?
Cross-Over Studies
1
2010
117
0.040
Why?
Concept Formation
1
2009
16
0.040
Why?
Placebos
1
2010
177
0.040
Why?
Disease Susceptibility
1
2009
77
0.040
Why?
Case-Control Studies
1
2010
587
0.040
Why?
Computers
1
2007
81
0.040
Why?
Double-Blind Method
1
2010
985
0.040
Why?
Trinucleotide Repeats
1
2007
41
0.040
Why?
Cohort Studies
1
2010
912
0.040
Why?
Prospective Studies
1
2011
1606
0.040
Why?
Mutation
1
2012
1183
0.030
Why?
Pediatrics
1
2010
376
0.030
Why?
Follow-Up Studies
1
2010
1757
0.030
Why?
Infant
1
2011
2102
0.030
Why?
Models, Biological
1
2009
982
0.030
Why?
Retrospective Studies
1
2010
2167
0.030
Why?
RNA, Messenger
1
2010
1791
0.030
Why?
Feasibility Studies
1
2004
189
0.030
Why?
Hand
1
2004
73
0.030
Why?
Risk Factors
1
2009
2172
0.030
Why?
Reference Values
1
2004
427
0.030
Why?
Treatment Outcome
1
2010
2487
0.030
Why?
Protein-Serine-Threonine Kinases
1
2004
243
0.020
Why?

Visualizations


Martens's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department